COMPANY PROFILE / #3529
Biobot
Singapore, SingaporeVenture Capital-Backed
OVERVIEW
Developer of a robotic-assisted prostate intervention system designed to support prostate cancer diagnosis and treatment. The company develops a robotic platform that combines MRI-ultrasound image fusion, robotic needle positioning, and biopsy planning software for transperineal prostate biopsy and soft tissue ablation procedures, enabling healthcare providers to perform precise prostate interventions.
已融资54.33
最新估值54.28
员工数47
成立年份2007
公司概况
- Companies
- Biobot
- Description
- Developer of a robotic-assisted prostate intervention system designed to support prostate cancer diagnosis and treatment. The company develops a robotic platform that combines MRI-ultrasound image fusion, robotic needle positioning, and biopsy planning software for transperineal prostate biopsy and soft tissue ablation procedures, enabling healthcare providers to perform precise prostate interventions.
- Website
- www.biobotsurgical.com
- HQ Location
- Singapore, Singapore
- Year Founded
- 2007
- Keywords
- biopsy technology, cancer diagnosis product, clinical outcomes, imaging equipment, medical robotics, prostate biopsy, prostate cancer, robotic systems
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 54.33
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 01-Jun-2026
- Last Financing Deal Type
- Secondary Transaction - Private
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 54.28
- Last Known Valuation Date
- 07-Mar-2024
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 41.98
- Valuation Estimate Growth Rate
- -22.66%
- Active Investors
- Andreas Handayanto, Ang Tiam, Astrid Hill Investment, Chia Chee Ming, ClavystBio, Jia Yu Capital, Kupa, Mark Keng Hong Wee, MicroPort Scientific, Pao Chuen Lui, PTSM holding, Tony Tan Choon Keat, Zicom Equipment, ZIG Ventures
- # Active Investors
- 14
- Acquirers
- —
团队与联系人
- Employees
- 47
- Employee Growth %
- 20.51%
- Employee History
- 2026: 47, 2025: 39, 2024: 35, 2023: 29, 2022: 14
- Primary Contact
- Kok Hwee Sim
- Primary Contact Title
- Executive Deputy Chairman & Board Member
- Primary Contact Email
- —
- Primary Contact Phone
- +65 6351 1861
增长与经营
- Revenue
- 1.36
- Revenue Growth %
- -21.89%
- Growth Rate
- 0.56%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 95
- Size Multiple
- 3.44x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 76
- Majestic Referring Domains
- 50
- SimilarWeb Unique Visitors
- 0
- SimilarWeb Unique Visitors Change
- 0
- SimilarWeb Growth Rate
- 0.00%
- SimilarWeb Growth Rate Percentile
- 9
- Success Probability Over Time – 1 Year
- 17%
- Success Probability Over Time – 3 Year
- 35%
- Success Probability Over Time – 5 Year
- 53%
记录来源：public.companies · 原始序号 #3529 · 所有字段均按数据库原值展示。